Pols H, Zandbergen J, Lousberg H, de Loof C, Griez E
Department of Clinical Psychiatry, State University of Maastricht, The Netherlands.
Can J Psychiatry. 1991 May;36(4):302-3. doi: 10.1177/070674379103600413.
In order to assess the efficacy of a high-potency benzodiazepine in the treatment of panic disorder, an open trial was conducted with clonazepam. Clonazepam was administered in relatively low doses and, after four weeks, was shown to be effective in reducing the number of panic attacks and associated features of the disorder.
为了评估一种高效苯二氮䓬类药物治疗惊恐障碍的疗效，开展了一项使用氯硝西泮的开放性试验。氯硝西泮以相对低剂量给药，四周后显示出能有效减少惊恐发作的次数及该障碍的相关症状。
